BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Arvinas Collaborators Present Data On BET PROTAC Degraders At 2016 American Society of Hematology Annual Meeting

  December 6, 2016

   · 

  4 min read
• Drug Development

  Bristol-Myers Squibb Release: Opdivo (Nivolumab) Alone Or Combined With Yervoy (Ipilimumab) Shows Encouraging Response And Survival Rates In Recurrent Small Cell Lung Cancer, From Phase I/II Study Checkmate -032

  December 6, 2016

   · 

  20 min read
• Biotech Beach

  Janssen Pharmaceutical Release: New Analysis Shows People With Cancer Who Received XARELTO (Rivaroxaban) For Blood Clots Had Fewer ER Visits And Lower Healthcare Costs Than Those Given Standard Treatment

  December 6, 2016

   · 

  16 min read
• Drug Development

  Kadmon Presents Encouraging Data On Tesevatinib In EGFR-Mutated Non-Small Cell Lung Cancer With Brain Metastases And/Or Leptomeningeal Metastases

  December 6, 2016

   · 

  7 min read
• Drug Development

  Merck & Co. Release: Updated KEYTRUDA (Pembrolizumab) Data In Small Cell Lung Cancer And Mesothelioma Presented At 17th World Conference On Lung Cancer

  December 6, 2016

   · 

  17 min read
• Business

  Royal Philips Electronics N.V. Strengthens Collaboration With Leading Medical And Academic Institutions To Innovate In Personalized Health Solutions

  December 6, 2016

   · 

  4 min read
• Drug Development

  Ariad Announces Data Presentations At American Society of Hematology Meeting

  December 6, 2016

   · 

  1 min read
• Business

  Almac Group Announces Strategic Partnership With inVentiv Health

  December 6, 2016

   · 

  3 min read
• Pluristem Therapeutics’s PLX-R18 Advances Into Second Cohort Of Dose Selection Study For Treatment Of Acute Radiation Syndrome

  December 6, 2016

   · 

  4 min read
• Drug Development

  Janssen R&D Release: Late-breaking Phase 2 Ibrutinib Study In Chronic Graft-Versus-Host-Disease (cGVHD) Showed Complete Or Partial Response In Up To Two-Thirds Of Steroid Dependent Or Refractory Patients

  December 6, 2016

   · 

  11 min read